MarketersMEDIA / Newsroom / Viral Gastroenteritis Market 2019 Size, Share, Trends, Comphrensive Research, Significant Portion, analysed By Global Companies Forecast to 2023

Viral Gastroenteritis Market 2019 Size, Share, Trends, Comphrensive Research, Significant Portion, analysed By Global Companies Forecast to 2023

Share This Press Release

Viral Gastroenteritis Market report by Market Research Future, provides an in-depth analysis of regional data with Growth Potential, Opportunities, Drivers, Industry-Specific Challenges

— Rising prevalence of Gastrointestinal Disease across the globe, demand for new drugs for the treatment and increasing expenses on research and development in gastroenterology fuel the market growth. Additionally, the growing concerns about the spread of the disease among children and an urgent need to manage viral gastroenteritis also contribute to the market growth.

Viral Gastroenteritis is one of the common gastrointestinal disease across the globe. It is a communicable disease transmitted through contaminated food or water and direct contact with the infected person. Notovirus is the common cause of viral gastritis in various developed and developing countries across the globe.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/4438

Fierce competition among key market players acts as a barrier for the new entrant in the market.

The global viral gastroenteritis market is expected to grow at a CAGR of 7.5% during the forecast period.

Bacterial resistance to commonly used antibiotics such as penicillin and amoxicillin may be the leading restrain for the growth of the market. Fierce competition among key market players acts as a barrier for the new entrant in the market.

According to the World Health Organization (WHO), diarrheal diseases are a major cause of hospitalizations and child deaths globally.

Key Players 

Valeant Pharmaceuticals International Inc. (U.S.),
Janssen Global Services, LLC (U.S.),
Takeda Pharmaceutical (Japan),
Bayer AG (Germany),
Sanofi (France),
Allergan (Ireland),
GlaxoSmithKline (U.S.),
Abbott (U.S.),  
AstraZeneca (U.K).

Segmentation
                                                                                                                                     
The global viral gastroenteritis market is segmented on the basis of type of virus, diagnosis, drugs, indication, and end user.

On the basis of type of virus, market is segmented into norovirus, rotavirus, astrovirus, and enteric adenovirus.

On the basis of diagnosis, the market is segmented into physical examination and rapid stool test.

On the basis of end user, the market is segmented into hospitals, clinics, pharmaceutical companies, diagnostic centers, ambulatory care centers and others.

On the basis of drugs, the market is segmented into Antibiotics, antacids, laxatives, antimotility agents and others. Other drugs are antiemetics and chemotherapy drugs.

On the basis of indication, the market is segmented into watery diarrhea, vomiting, abdominal cramps and pain and others.

Browse Premium Research Report @ https://www.marketresearchfuture.com/reports/viral-gastroenteritis-market-4438

Regional Analysis   

In Asia Pacific, the common cause of severe gastroenteritis in children less than 5 years of age, is rotavirus. The market in Asia Pacific is driven by an increasing demand for rapid diagnostic tests for gastrointestinal diseases and increasing awareness about available treatment options for viral gastroenteritis. Also, growing investments in the field of life science research and demand for advanced therapies for the treatment of gastrointestinal diseases in developing nations such as China and India will propel the growth of the Asia Pacific market.

America is the largest market for viral gastroenteritis owing to rising prevalence of viral gastroenteritis in the U.S., especially among the pediatric population. According to the Center For Disease Control And Prevention (CDC), each year on average in the United States, there are 19 to 21 million cases of acute gastroenteritis.

Europe is the second largest market for viral gastroenteritis. According to an article published in the journal of Clinical Virology, in Europe, acute infectious gastroenteritis is one of the major causes for substantial morbidity and economic loss.

The Middle East & Africa also show a steady rise in the market owing to increasing number of cases of diarrhea due to viral infection.

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/4438

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/viral-gastroenteritis-market-4438

Source URL: https://marketersmedia.com/viral-gastroenteritis-market-2019-size-share-trends-comphrensive-research-significant-portion-analysed-by-global-companies-forecast-to-2023/88909072

Source: MarketersMedia

Release ID: 88909072

Subscribe and Receive exclusive insider tips and tricks on Press Release.

Follow Us

Copyright © 2012 - 2019 MarketersMEDIA – Press Release Distribution Services – News Release Distribution Services. All Rights Reserved.

Powered by Semantics BigData Analytics (SBDA).